NanoAntibiotics Inc., a development stage company focused on the discovery, development, and commercialization of novel drug therapies, announces the acquisition of LAT Pharma LLC, of Chicago, IL, an early-stage biotechnology company developing novel medicines to treat life-threatening complications of liver cirrhosis. LAT Pharma brings a promising new therapeutic opportunity to NanoAntibiotics. Earlier this year LAT Pharma met…
CA to Vote on Recreational Marijuana Legalization
BriaCell Files Patent Application for Cancer Vaccines
Marijuana Breathalyzer Development
Microlin Bio to Acquire Nucleic Acid Therapeutic Assets of Marina Biotech
Data Platform for Personalized Cancer Treatment
Critical Outcome Technologies Inc. announced today the launch of ROSALIND™, a smart data platform designed to provide personalized drug treatment options for cancer patients based on the genetic mutation and expression profile of an individual’s tumor. Using advanced algorithms for dealing with big data problems, ROSALIND makes it possible to evaluate what available drug treatments may be effective for an individual’s…